Empresstx
1 known investors
Empress provides drug discovery teams with an industrialized Perturb-seq platform that combines CRISPR-based single-cell functional genomics, chemoproteomics, and multi-omics with causal machine learning to identify what drives activity, efficacy, and risk. It serves pharmaceutical and biotech R&D teams seeking mechanistic understanding of drug targets.
Investors · 1
Frequently asked questions
- What does Empresstx do?
- Empress provides drug discovery teams with an industrialized Perturb-seq platform that combines CRISPR-based single-cell functional genomics, chemoproteomics, and multi-omics with causal machine learning to identify what drives activity, efficacy, and risk. It serves pharmaceutical and biotech R&D teams seeking mechanistic understanding of drug targets.
- Who are Empresstx's investors?
- Empresstx's investors include J2 Ventures.